1. |
Blot S, Antonelli M, Arvaniti K, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project. Intensive Care Med, 2019, 45(12): 1703-1717.
|
2. |
Chou EH, Mann S, Hsu TC, et al. Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: a nationwide study. PLoS One, 2020, 15(1): e0227752.
|
3. |
況剛, 陳勇, 魏旭升, 等. 24 h LCR、SOFA 評分及 SAPSⅡ評分在腹腔感染致膿毒癥患者預后評估中的作用. 湖南師范大學學報(醫學版), 2020, 17(1): 26-29.
|
4. |
Qu Z, Zhu Y, Wang M, et al. Prognosis and risk factors of sepsis patients in Chinese ICUs: a retrospective analysis of a cohort database. Shock, 2021, 56(6): 921-926.
|
5. |
Dadkhah A, Fatemi F, Rasooli A, et al. Assessing the effect of Mentha longifolia essential oils on COX-2 expression in animal model of sepsis induced by caecal ligation and puncture. Pharm Biol, 2018, 56(1): 495-504.
|
6. |
劉勝蕊, 史曉峰, 王兵, 等. 腹腔感染性膿毒癥可溶性髓樣細胞觸發受體(sTREM-1)與 Janus 激酶-信號轉導和轉錄激活因子(JAK/STAT)通路的關系. 中華急診醫學雜志, 2016, 25(3): 314-319.
|
7. |
李瑞萍, 宋偉. 血漿 sTREM-1、sFLT-1 及 APACHEⅡ評分對重癥肺炎患者預后評估價值. 國際呼吸雜志, 2018, 38(13): 968-971.
|
8. |
Verma AK, Pandey AK, Singh A, et al. Increased serum levels of matrix-metalloproteinase-9, cyclo-oxygenase-2 and prostaglandin E-2 in patients with chronic obstructive pulmonary disease (COPD). Indian J Clin Biochem, 2022, 37(2): 169-177.
|
9. |
中華醫學會外科學分會外科感染與重癥醫學學組, 中國醫師協會外科醫師分會腸瘺外科醫師專業委員會. 中國腹腔感染診治指南(2019 版). 中國實用外科雜志, 2020, 40(1): 1-16.
|
10. |
中國醫師協會急診醫師分會, 中國研究型醫院學會休克與膿毒癥專業委員會. 中國膿毒癥/膿毒性休克急診治療指南(2018). 中國急救醫學, 2018, 38(9): 741-756.
|
11. |
魏鋒, 洪志敏, 董海濤, 等. ICU 重度膿毒癥的流行病學特點及預后影響因素的分析. 中華醫院感染學雜志, 2018, 28(10): 1469-1471, 1484.
|
12. |
陶麗麗, 張振輝, 張瑞昌, 等. 綜合 ICU 內腹腔感染相關性膿毒癥患者的臨床特征分析. 國際醫藥衛生導報, 2018, 24(23): 3604-3606.
|
13. |
Wang L, Chen Q, Yu Q, et al. ITREM-1 aggravates chronic obstructive pulmonary disease development via activation NLRP3 inflammasome-mediated pyroptosis. Inflamm Res, 2021, 70(9): 971-980.
|
14. |
Wang X, Luo B, Lu Y, et al. The triggering receptor expressed by myeloid cells-1 activates TLR4-MyD88-NF-κB-dependent signaling to aggravate ventilation-induced lung inflammation and injury in mice. Cell Tissue Res, 2018, 374(1): 137-148.
|
15. |
Gon?alves RM, Delgobo M, Agnes JP, et al. COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice. Cancer Lett, 2021, 1(502): 44-57.
|
16. |
Xie Y, Li X, Lv D, et al. TREM-1 amplifies trophoblastic inflammation via activating NF-κB pathway during preeclampsia. Placenta, 2021, 115: 97-105.
|
17. |
Tang J, Dong Q, Tang J, et al. Knockdown of TREM-1 suppresses IL-1β-induced chondrocyte injury via inhibiting the NF-κB pathway. Biochem Biophys Res Commun, 2017, 482(4): 1240-1245.
|
18. |
Joung EJ, Cao L, Lee B, et al. Sargahydroquinoic acid, a cyclooxygenase-2 inhibitor, attenuates inflammatory responses by regulating NF-κB inactivation and Nrf2 activation in lipopolysaccharide-stimulated cells. Inflammation, 2021, 44(5): 2120-2131.
|